Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
160 hedge funds and large institutions have $2.25B invested in Axonics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 55 increasing their positions, 52 reducing their positions, and 23 closing their positions.
57% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 23
30% more capital invested
Capital invested by funds: $1.74B → $2.25B (+$513M)
7% more funds holding
Funds holding: 149 → 160 (+11)
6% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 52
6% less call options, than puts
Call options by funds: $16M | Put options by funds: $17M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$34.8M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$29.2M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$21.2M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$20.1M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$15.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$39.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.3M |
| 3 |
SC
Samlyn Capital
New York
|
-$9.62M |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$9.34M |
| 5 |
OCM
Osterweis Capital Management
San Francisco,
California
|
-$7.96M |
AXNX Hedge Fund Activity: Q1 2021 in Review
160 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q1 2021, worth a combined $2.25B — up 30% from $1.74B a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new AXNX positions and 23 closed out — a net gain of 13 holders — while 55 added to existing stakes and 52 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $34.8M. The largest seller was Deerfield Management, exiting entirely with an estimated $39.9M sold.
- 160 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q1 2021, up from 149 in Q4 2020.
- Funds reported $2.25B of Axonics, Inc. Common Stock stock for Q1 2021, up 30% quarter-over-quarter.
- 36 funds opened new Axonics, Inc. Common Stock positions in Q1 2021 and 23 closed out, a net change of +13 holders.
- The largest Axonics, Inc. Common Stock buyer in Q1 2021 was Citadel Advisors, an estimated $34.8M added.
- The largest Axonics, Inc. Common Stock seller in Q1 2021 was Deerfield Management, an estimated $39.9M sold.
Based on aggregated 13F filings for Q1 2021.